MedTrace Logo

Risks of Intermittent Fasting in Patients With Primary Adrenal Insufficiency

NCT06299020 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2025-02-14

No results posted yet for this study

Summary

In primary adrenal insufficiency, there is an increased risk of hypoglycaemia and dehydration. These risks have been little studied particularly during intermittent fasting. The present study aimed to assess these risks in a prospective study of 30 subjects with primary adrenal insufficiency. Patients will undergo a clinical examination, blood sampling and continuous glucose monitoring for fourteen days (one week of fasting and one week of non-fasting).

Conditions

  • Primary Adrenal Insufficiency
  • Intermittent Fasting

Interventions

BEHAVIORAL

intermittent fasting

fasting from predawn to sunset (no eating and no drinking), for approximately 16 hours.

Sponsors & Collaborators

  • Hopital La Rabta

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
20 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-03-04
Primary Completion
2024-04-20
Completion
2024-12-01

Countries

  • Tunisia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06299020 on ClinicalTrials.gov